PF487 MAJOR RESPONSES IN MYD88 WILDTYPE (MYD88WT) WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB-3111)
暂无分享，去创建一个
M. Dimopoulos | C. Buske | S. Opat | C. Tam | A. Tedeschi | V. Leblond | A. Cohen | R. Owen | W. Chan | S. D'Sa | J. Huang | R. G. Sanz | G. Cull | H.-P. Lee | M. Varettoni | J. Schneider | M. Osman | S. D’Sa